(Q37803528)

23 August 2017

Reactive oxygen species and vascular biology: implications in human hypertension (English)

1 reference

23 August 2017

arterial hypertension

0 references

reactive oxygen species

1 reference

0 references

1

1 reference

23 August 2017

Ana M Briones

2

1 reference

23 August 2017

28 October 2010

1 reference

23 August 2017

Hypertension Research

1 reference

23 August 2017

34

1 reference

23 August 2017

1

1 reference

23 August 2017

5-14

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.201

23 August 2017

0 references

cites work

Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

GPCR signalling in hypertension: role of GRKs

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Immune regulation and vascular inflammation in genetic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Molecular mechanisms of hypertension: role of Nox family NADPH oxidases

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Reactive oxygen species in vascular biology: implications in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Free radicals in the physiological control of cell function

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

ATVB in focus: redox mechanisms in blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Endothelial mechanotransduction, nitric oxide and vascular inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Peroxynitrite is Involved in the dysfunction of vasorelaxation in SHR/NDmcr-cp rats, spontaneously hypertensive obese rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: evidence of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Treatment of hypertension with ascorbic acid

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Is the anti-hypertensive effect of dietary supplements via aldehydes reduction evidence based? A systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Superoxide anion radical (O2-.), superoxide dismutases, and related matters

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Superoxide dismutases and their impact upon human health

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Vascular protection: superoxide dismutase isoforms in the vessel wall

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

SOD isoforms and signaling in blood vessels: evidence for the importance of ROS compartmentalization

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Relationships between nitric oxide-mediated endothelial function, eNOS coupling and blood pressure revealed by eNOS-GTP cyclohydrolase 1 double transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Tetrahydrobiopterin and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Microvascular display of xanthine oxidase and NADPH oxidase in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mechanisms by which mitochondria transport calcium

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

The mitochondrial permeability transition.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mitochondrial energy conversion disturbance with decrease in ATP production as a source of systemic arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mitochondrial ROS-induced ROS release: an update and review

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

From mitochondria to disease: role of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Maternal influence on blood pressure suggests involvement of mitochondrial DNA in the pathogenesis of hypertension: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Role of nitric oxide-induced mtDNA damage in mitochondrial dysfunction and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

The putative role of mitochondrial dysfunction in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Novel isoforms of NADPH-oxidase in cerebral vascular control.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

https://api.crossref.org/works/10.1038%2FHR.2010.201

1 reference

7 January 2021

The superoxide-generating NADPH oxidase: structural aspects and activation mechanism

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

A region N-terminal to the tandem SH3 domain of p47phox plays a crucial role in the activation of the phagocyte NADPH oxidase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Regulation of the phagocyte NADPH oxidase by Rac GTPase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NADPH oxidases: new kids on the block

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NADPH oxidases in cardiovascular health and disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NADPH oxidases: functions and pathologies in the vasculature

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Activation of NADPH oxidase 1 in tumour colon epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Protein disulfide isomerase overexpression in vascular smooth muscle cells induces spontaneous preemptive NADPH oxidase activation and Nox1 mRNA expression: effects of nitrosothiol exposure.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Vascular NAD(P)H oxidases: specific features, expression, and regulation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Regulation of renal medullary circulation by the renin-angiotensin system in genetically hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Molecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NOX2 and NOX4 mediate proliferative response in endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Regulation of ROS signal transduction by NADPH oxidase 4 localization

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NOX5 variants are functionally active in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NOX5, a new "radical" player in human atherosclerosis?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Nox4 acts as a switch between differentiation and proliferation in preadipocytes.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Regulation of novel superoxide-producing NAD(P)H oxidases

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Noxa1 is a central component of the smooth muscle NADPH oxidase in mice.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Alternative mRNA splice forms of NOXO1: differential tissue expression and regulation of Nox1 and Nox3.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

5-HT evokes sensory long-term facilitation of rodent carotid body via activation of NADPH oxidase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Differential vascular functions of Nox family NADPH oxidases

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Role of extracellular superoxide dismutase in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Expression of catalase and glutathione peroxidase in renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

The redox state of glutathione regulates the hypoxic induction of HIF-1.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Redox control of calcium channels: from mechanisms to therapeutic opportunities.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Nitric-oxide-induced vasodilatation: regulation by physiologic s-glutathiolation and pathologic oxidation of the sarcoplasmic endoplasmic reticulum calcium ATPase.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Oxidant-redox regulation of pulmonary vascular responses to hypoxia and nitric oxide-cGMP signaling

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mitochondrial-derived hydrogen peroxide inhibits relaxation of bovine coronary arterial smooth muscle to hypoxia through stimulation of ERK MAP kinase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mitochondria and hypoxia-induced gene expression mediated by hypoxia-inducible factors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Crosstalk signaling between mitochondrial Ca2+ and ROS.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Vascular signaling through cholesterol-rich domains: implications in hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Reactive oxygen species in the neuropathogenesis of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NADPH oxidases in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Endothelial function and oxidative stress in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Neutrophil activation and production of reactive oxygen species in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Greater oxidative stress in healthy young men compared with premenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Determinants of platelet activation in human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Oxidative stress in human in sustained and white coat hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Serum antioxidant vitamins and blood pressure in the United States population

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Recent trials of antioxidant therapy: what should we be telling our patients?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Antioxidants and atherosclerosis: don't throw out the baby with the bath water

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Lack of effect of acute oral ingestion of vitamin C on oxidative stress, arterial stiffness or blood pressure in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Childhood and adult dietary vitamin E intake and cardiovascular risk factors in mid-life in the 1946 British Birth Cohort

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Vitamin E in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Nutrition and nutraceutical supplements in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Selective targeting of NADPH oxidase for cardiovascular protection

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Therapeutic strategies by modulating oxygen stress in cancer and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Oxidative stress and vascular function: implications for pharmacologic treatments

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Antioxidants and beneficial microvascular effects: is this the remedy?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Targeting reactive oxygen species in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Nifedipine improves endothelial function: role of endothelial progenitor cells.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Vitamins C and E to prevent complications of pregnancy-associated hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasison vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Role of proinflammatory cytokines and redox homeostasis in exercise-induced delayed progression of hypertension in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.201

7 January 2021

Identifiers

DOI

10.1038/HR.2010.201

1 reference

23 August 2017

1 reference

PubMed ID

20981034